11/23/2020 | FierceBiotech
Merck inks $425M OncoImmune buyout to bag COVID-19 drug
09/25/2020 | Pharmaceutical Business Review
OncoImmune’s SACCOVID demonstrates significant therapeutic efficacy in Covid-19 trial
09/10/2020 | FinSMEs
OncoImmune Raises $56M Series B Financing
09/09/2020 | Maryland Daily Record
OncoImmune raises $56M in Series B financing for novel cancer and COVID-19 therapeutics
09/09/2020 | FierceBiotech
OncoImmune nabs $56M round for late-stage COVID-19 tests, leukemia treatment
09/09/2020 | Endpoint News
OncoImmune pulls in $56M Series B, hoping GvHD program can prove useful for Covid-19
12/30/2019 | UMB News
New Theory For Cancer Immunotherapy